Blog by: Al Sisto - Oct 31, 2019 12:34:18 PM
Blog by: Al Sisto - Jun 24, 2019 7:05:00 AM
Blog by: Al Sisto - Apr 23, 2019 9:00:00 AM
Blog by: Al Sisto - Apr 15, 2019 1:00:00 PM
Tern PLC
Gridiron
One Pancras Square
London, N1C 4AG
e info@ternplc.com
t 0203 807 0222
Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things (“IoT”), is pleased to announce that its portfolio company, FVRVS Limited (“FundamentalVR”), has secured a further £0.4 million contract with an existing client, one of the world’s leading pharmaceutical companies (the “Client”), to support training and adoption of its Ocular Gene Therapy product.
Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things (“IoT”), is pleased to announce that its portfolio company, FVRVS Limited (“FundamentalVR”), has secured a three year contract worth a minimum of £0.9 million from a new client, which is a global medical device company (the “Client”), to accelerate the adoption, and subsequent safe and compliant use, of the Client’s product.
© Tern PLC | Sitemap | Terms & Conditions | Privacy Policy
B2B website design by Axon Garside